Arrowhead Research reported $454.47M in Equity Capital and Reserves for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alnylam Pharmaceuticals ALNY:US $ 1016.25M 198.78M
Anika Therapeutics ANIK:US $ 284.45M 3.99M
Arrowhead Research ARWR:US $ 454.47M 7.31M
Cerulean Pharma CERU:US $ -1.39M 1.7M
Heron Therapeutics HRTX:US $ 236.49M 40.66M
Ligand Pharmaceuticals LGND:US $ 709.52M 11.7M
Opko Health OPK:US $ 1671.55M 47.78M
Sarepta Therapeutics SRPT:US $ 892.05M 150.82M
Spectrum Pharmaceuticals SPPI:US $ 168.36M 37.76M
Tg Therapeutics TGTX:US $ 170.66M 23.57M
Ultragenyx Pharmaceutical RARE:US $ 1154.38M 488.18M
Vertex Pharmaceuticals VRTX:US $ 8686.82M 553.34M
YTE INCY:US $ 2611.27M 220.44M